Motives of foreign pharmaceutical firms' FDI in China: a comparison between eastern and western firms
Access Status
Authors
Date
2004Type
Metadata
Show full item recordCitation
Source Title
ISSN
School
Collection
Abstract
This study examined the determinants of foreign pharmaceutical firms' foreign direct investments (FDI) in China, and compared FDI determinants between eastern and western pharmaceutical firms. The analysis suggested that foreign pharmaceutical firms' FDI in China was determined by China's specific advantages, and China's market size played the most important role. China's incentive policy received moderate attention, and low labour cost was not a significant consideration. The results did not support the traditional FDI theories of market imperfection and firm specific advantages. The results also showed that eastern firms had a tendency to agree that the incentive policies was one of the China's specific attractions which attracted their FDI to China, whereas, western firms tended to disagree. Both eastern and western firms were unlikely to consider China's low labour cost as an important factor in their decision to invest in China, this being even more so for western firms.
Related items
Showing items related by title, author, creator and subject.
-
Liu, Yi (2012)Since Jim O’Neill, the Goldman Sachs economist, coined the acronym of the BRIC countries in 2001 the concept has attracted an infectious logic. The growth of the four BRIC countries, Brazil, Russia, India, and China, is ...
-
Luo, Yadong; Zheng, Q. (2016)© Emerald Group Publishing Limited. Purpose - The purpose this paper is to comment on the "Global Implications of the Indigenous Epistemological System from the East: How to Apply Yin-Yang Balancing to Paradox Management" ...
-
Liu, Yi (2008)The growing economic importance of China with its major economic power in the East Asia region has become a popular host destination for receiving foreign investment from Hong Kong, Korea, and Taiwan. With China’s growth ...